These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 11684837)

  • 1. Effects of enalapril and L-158809 on myocardial beta-adrenergic receptor density in transplanted rat hearts.
    Nakame T; Iguchi A; Tabayashi K
    Eur Surg Res; 2001; 33(4):297-302. PubMed ID: 11684837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New approach in the therapy of chronic rejection? ACE- and AT1-blocker reduce the development of chronic rejection after cardiac transplantation in a rat model.
    Richter M; Skupin M; Grabs R; Schramm D; Richter H; Olbrich HG
    J Heart Lung Transplant; 2000 Nov; 19(11):1047-55. PubMed ID: 11077221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do vascular compartments differ in the development of chronic rejection? AT(1) blocker candesartan versus Ace blocker enalapril in an experimental heart transplant model.
    Richter M; Richter H; Skupin M; Mohr FW; Olbrich HG
    J Heart Lung Transplant; 2001 Oct; 20(10):1092-8. PubMed ID: 11595564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of angiotensin-converting enzyme inhibition on growth factor mRNA in chronic renal allograft rejection in the rat.
    Szabo A; Lutz J; Schleimer K; Antus B; Hamar P; Philipp T; Heemann U
    Kidney Int; 2000 Mar; 57(3):982-91. PubMed ID: 10720951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effects of type 1 angiotensin II-receptor blockade with angiotensin-converting-enzyme inhibitor on left ventricular distensibility and collagen metabolism in spontaneously hypertensive rats.
    Yonezawa T; Umemoto S; Fujii A; Katayama K; Matsuzaki M
    J Cardiovasc Pharmacol; 1996 Jan; 27(1):119-24. PubMed ID: 8656644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of the renin-angiotensin system improves cerebral microcirculatory perfusion in diabetic hypertensive rats.
    Estato V; Obadia N; Carvalho-Tavares J; Freitas FS; Reis P; Castro-Faria Neto H; Lessa MA; Tibiriçá E
    Microvasc Res; 2013 May; 87():41-9. PubMed ID: 23466285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two good reasons for an angiotensin-II type 1 receptor blockade with losartan after cardiac transplantation: reduction of incidence and severity of transplant vasculopathy.
    Richter MH; Richter HR; Olbrich HG; Mohr FW
    Transpl Int; 2003 Jan; 16(1):26-32. PubMed ID: 12545338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin II receptor antagonist TCV-116 reduces graft coronary artery disease and preserves graft status in a murine model. A comparative study with captopril.
    Furukawa Y; Matsumori A; Hirozane T; Sasayama S
    Circulation; 1996 Jan; 93(2):333-9. PubMed ID: 8548907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin receptor blockers improve insulin signaling and prevent microvascular rarefaction in the skeletal muscle of spontaneously hypertensive rats.
    Rizzoni D; Pasini E; Flati V; Rodella LF; Paiardi S; Assanelli D; De Ciuceis C; Porteri E; Boari GE; Rezzani R; Speca S; Favero G; Martinotti S; Toniato E; Platto C; Agabiti-Rosei E
    J Hypertens; 2008 Aug; 26(8):1595-601. PubMed ID: 18622238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term treatment with angiotensin I-converting enzyme inhibitors attenuates the loss of cardiac beta-adrenoceptor responses in rats with chronic heart failure.
    Sanbe A; Takeo S
    Circulation; 1995 Nov; 92(9):2666-75. PubMed ID: 7586371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The angiotensin receptor antagonist, irbesartan, reduces renal injury in experimental chronic renal failure.
    Ziai F; Ots M; Provoost AP; Troy JL; Rennke HG; Brenner BM; Mackenzie HS
    Kidney Int Suppl; 1996 Dec; 57():S132-6. PubMed ID: 8941934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in myocardial beta-adrenergic receptors during acute rejection of heterotopically transplanted rat hearts.
    Yokoyama H; Ohmi M; Iguchi A; Murata S; Nakame T; Tabayashi K; Mohri H
    J Thorac Cardiovasc Surg; 1992 Dec; 104(6):1567-71. PubMed ID: 1333553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radionuclide imaging of angiotensin II type 1 receptor upregulation after myocardial ischemia-reperfusion injury.
    Higuchi T; Fukushima K; Xia J; Mathews WB; Lautamäki R; Bravo PE; Javadi MS; Dannals RF; Szabo Z; Bengel FM
    J Nucl Med; 2010 Dec; 51(12):1956-61. PubMed ID: 21078800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Additional effects of endothelin receptor blockade and angiotensin converting enzyme inhibition in rats with chronic heart failure.
    Qiu CB; Qiu CS; Hess P; Clozel JP; Clozel M
    Acta Pharmacol Sin; 2001 Jun; 22(6):541-8. PubMed ID: 11747762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II type 1 receptor blockade after cardiac transplantation reduced the incidence and severity of transplant vasculopathy in an animal-based study.
    Richter MH; Richter H; Barten M; Schramm D; Gummert J; Mohr FW; Skupin M; Olbrich HG
    Transplant Proc; 2002 Aug; 34(5):1484-5. PubMed ID: 12176450
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of temocapril and olmesartan on myocardial sympathetic nervous activity and fatty acid metabolism in rats with chronic beta-adrenergic stimulation.
    Ido A; Hasebe N; Takeuchi T; Kikuchi K
    J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S133-7. PubMed ID: 12688410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined angiotensin II AT1-receptor blockade and angiotensin I-converting enzyme inhibition on survival and cardiac remodeling in chronic heart failure in rats.
    Richer C; Fornes P; Domergue V; De Gasparo M; Giudicelli JF
    J Card Fail; 2001 Sep; 7(3):269-76. PubMed ID: 11561229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective downregulation of rat cardiac beta 1-adrenoceptors by cyclosporine A: prevention by diltiazem or angiotensin-converting enzyme inhibitors.
    Brodde OE; Adamczyk M; Busch F; Bossaller C; Duske E; Fleck E; Götze S; Auch-Schwelk W
    J Am Coll Cardiol; 1995 Mar; 25(3):761-7. PubMed ID: 7860926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TCV-116 reduces chronic rejection in a rat heterotopic cardiac transplant model.
    Richter M; Westphal M; Maybaum B; Richter H; Skupin M; Mohr FW; Olbrich HG
    Transplant Proc; 1999; 31(1-2):106-7. PubMed ID: 10083031
    [No Abstract]   [Full Text] [Related]  

  • 20. Angiotensin-converting enzyme inhibition and angiotensin AT1 receptor blockade downregulate angiotensin-converting enzyme expression and attenuate renal injury in streptozotocin-induced diabetic rats.
    Motawi TK; El-Maraghy SA; Senousy MA
    J Biochem Mol Toxicol; 2013 Jul; 27(7):378-87. PubMed ID: 23733546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.